Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kaye

Showing results (641-650 of 740) with videos related to

Pageof 74
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|November 23, 2021
Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patientsPatrick O Hanafin, Roger L Nation, Marc H Scheetz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2019
The Pitt Bacteremia Score Predicts Mortality in Nonbacteremic InfectionsHeather Henderson, Courtney L Luterbach, Eric Cober, et al.
The American Journal of Medicine|December 28, 2005
Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomesVivian H Chu, David R Crosslin, Joelle Y Friedman, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptaseCorey R Hopkins, Mark Czekaj, Steven S Kaye, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2024
Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant EnterobacteralesGregory Weston, Abhigya Giri, Lauren Komarow, et al.
The Annals of Pharmacotherapy|December 6, 2012
Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agentsMichelle L Campbell, Dror Marchaim, Jason M Pogue, et al.
Nature Communications|August 1, 2022
Combined comparative genomics and clinical modeling reveals plasmid-encoded genes are independently associated with Klebsiella infectionJay Vornhagen, Emily K Roberts, Lavinia Unverdorben, et al.
Infection Control and Hospital Epidemiology|September 25, 2015
The Complex Epidemiology of Carbapenem-Resistant Enterobacter Infections: A Multicenter Descriptive AnalysisTsilia Lazarovitch, Keren Amity, Joseph R Coyle, et al.
Infection Control and Hospital Epidemiology|May 3, 2023
Strategies to prevent surgical site infections in acute-care hospitals: 2022 UpdateMichael S Calderwood, Deverick J Anderson, Dale W Bratzler, et al.
British Journal of Cancer|August 2, 2006
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysisT Eisen, T Ahmad, K T Flaherty, et al.
Pageof 74

Showing results (641-650 of 740) with videos related to

Sort By:
Pageof 74
CPT: Pharmacometrics & Systems Pharmacology|November 23, 2021
Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patientsPatrick O Hanafin, Roger L Nation, Marc H Scheetz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2019
The Pitt Bacteremia Score Predicts Mortality in Nonbacteremic InfectionsHeather Henderson, Courtney L Luterbach, Eric Cober, et al.
The American Journal of Medicine|December 28, 2005
Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomesVivian H Chu, David R Crosslin, Joelle Y Friedman, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptaseCorey R Hopkins, Mark Czekaj, Steven S Kaye, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2024
Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant EnterobacteralesGregory Weston, Abhigya Giri, Lauren Komarow, et al.
The Annals of Pharmacotherapy|December 6, 2012
Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agentsMichelle L Campbell, Dror Marchaim, Jason M Pogue, et al.
Nature Communications|August 1, 2022
Combined comparative genomics and clinical modeling reveals plasmid-encoded genes are independently associated with Klebsiella infectionJay Vornhagen, Emily K Roberts, Lavinia Unverdorben, et al.
Infection Control and Hospital Epidemiology|September 25, 2015
The Complex Epidemiology of Carbapenem-Resistant Enterobacter Infections: A Multicenter Descriptive AnalysisTsilia Lazarovitch, Keren Amity, Joseph R Coyle, et al.
Infection Control and Hospital Epidemiology|May 3, 2023
Strategies to prevent surgical site infections in acute-care hospitals: 2022 UpdateMichael S Calderwood, Deverick J Anderson, Dale W Bratzler, et al.
British Journal of Cancer|August 2, 2006
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysisT Eisen, T Ahmad, K T Flaherty, et al.
Pageof 74